Available information for KEYTRUDA - Submission control number 220544

2.5 Clinical Overview

• Clinical Overview

2.7.1 Summary of Biopharmaceutic Studies and Associated Analytical Methods

• Summary of Biopharmaceutic Studies and Associated Analytical Methods

2.7.2 Summary of Clinical Pharmacology Studies

• Summary of Clinical Pharmacology Studies

2.7.3 Summary of Clinical Efficacy

• Summary of Clinical Efficacy

2.7.4 Summary of Clinical Safety

• Summary of Clinical Safety

5.3.5.1 Study Reports of Controlled Clinical Studies Pertinent to the Claimed Indication

Correlative Biomarker Analysis of KEYNOTE-001 (NSCLC Cohorts): Phase I Study of Single Agent MK-3475 in Patients with Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, and Non-Small Cell Lung Carcinoma

• Report Body